TORONTO, Dec. 27, 2010 (GLOBE NEWSWIRE) — Transition Therapeutics Inc. (“Transition” or “Company”) (TSX:TTH) (Nasdaq:TTHI) today announced that the Company and Elan Corporation, plc (“Elan”) (NYSE:ELN) have mutually agreed to modify their collaboration agreement for the development and commercialization of ELND005.
Under the terms of the modification, in lieu of a contractually required Phase 3 milestone [...] http://bit.ly/gQvEhW
No comments:
Post a Comment